Categories: News

StageZero Announces 2020 Year End Analyst and Investor Call

TORONTO, ON / ACCESSWIRE / March 31, 2021 / StageZero Life Sciences (“StageZero” or the “Company”) (TSX:SZLS) today announced that it will release its Fourth Quarter 2020 and Year End operational results after market close on Wednesday March 31, 2021. StageZero’s Chairman and CEO, James R Howard-Tripp, will host a conference call and online presentation at 8:30 am ET on Thursday April 1, 2021 to review the operational results and discuss business developments for the period and to date.

Analyst and Investor Call

Event Date: Thursday April 1, 2021
Time: 8:30 AM ET
Webcast Link: https://www.webcaster4.com/Webcast/Page/2082/40528
Participant Numbers: Toll Free: 877-407-8031

International: 201-689-8031
Replay Number: Toll Free: 877-481-4010
International: 919-882-2331

Replay Passcode: 40528

About StageZero Life Sciences, Ltd.

StageZero Life Sciences is dedicated to the early detection of multiple disease states through whole blood. The Company operates a CAP accredited and CLIA certified high complexity reference laboratory based in Richmond, Virginia. A specialist in PCR testing for the early identification of Cancer through blood, the Company is uniquely positioned to provide both COVID PCR testing (swab and saliva) and blood test analysis (Antibody testing). Our full service, telehealth platform includes access to physicians and phlebotomists who can prescribe and draw samples for individuals and groups. As we provide COVID-19 test during this Pandemic, we continue making progress with our mission to eradicate late stage cancers through early detection. Our next generation test, Aristotle®, is a multi-cancer panel for simultaneously screening for 10 cancers from a single sample of blood with high sensitivity and specificity for each cancer. www.stagezerolifesciences.com

Company Contacts:

James R. Howard-Tripp
Chairman & CEO

Rebecca Greco
Investor Relations
rgreco@stagezerols.com
Tel: 1-855-420-7140 Ext. 1838

SOURCE: StageZero Life Sciences Ltd

View source version on accesswire.com:
https://www.accesswire.com/638438/StageZero-Announces-2020-Year-End-Analyst-and-Investor-Call

Staff

Recent Posts

Patients Searching “Best Plastic Surgeon in America” Are Traveling for Clarity and Planning – Gruber Plastic Surgery Expands Out-of-Town Resources for 2026

Updated Fly-In Program outlines virtual consultations, travel timelines, recovery planning, and follow-up care for out-of-town…

1 hour ago

Dr. Kunaal Jindal Sheds Light on His Signature Mommy Makeover, Which Includes his High Definition Tummy Tuck with Liposculpting and Breast Reshaping

A closer look at the artistry, technique, and philosophy behind Dr. Jindal's most sought-after transformation.…

1 hour ago

Attune to Support Poppy Health’s $39M ARPA-H BREATHE Project in the U.S. Schools

VIENNA, Va., Dec. 19, 2025 /PRNewswire/ -- Attune announced today that the company will play…

4 hours ago

Feel30 Launches Austin-Based Telehealth Platform for Evidence-Proven TRT & Integrated At-Home Phlebotomy Services

AUSTIN, Texas, Dec. 19, 2025 /PRNewswire/ -- Feel30 , a telehealth platform specializing in testosterone…

4 hours ago

LISA LING JOINS TENDERCARE AS CHIEF CAREGIVER ADVOCATE & ADVISOR

– Will help address the difficult realities sandwich generation caregivers face with family caregiving –NEW…

4 hours ago

TENDERCARE LAUNCHING NATIONAL FAMILY CAREGIVING INFRASTRUCTURE, PARTNERING WITH THE AGING LIFE CARE ASSOCIATION® AND SUPPORTING THE CMS GUIDE MODEL PROGRAM

tendercare partnering with ALCA to raise national caregiving and eldercare industry standards;Selected as CMS GUIDE…

4 hours ago